参考文献/References:
[1]Osborn JW,Foss JD. Renal nerves and long-term control of arterial pressure[J]. Compr Physiol,2017,7(2):263-320.
[2]Ferguson M,Bell C. Substance P-immunoreactive nerves in the rat kidney[J]. Neurosci Lett,1985,60(2):183-188.
[3]Knight DS,Cicero S,Beal JA. Calcitonin gene-related peptide-immunoreactive nerves in the rat kidney[J]. Am J Anat,1991,190(1):31-40.
[4]Xie C,Sachs JR,Wang DH. Interdependent regulation of afferent renal nerve activity and renal function:role of transient receptor potential vanilloid type 1,neurokinin 1,and calcitonin gene-related peptide receptors[J]. J Pharmacol Exp Ther,2008,325(3):751-757.
[5]Gontijo JR,Smith LA,Kopp UC. CGRP activates renal pelvic substance P receptors by retarding substance P metabolism[J]. Hypertension,1999,33(1 Pt 2):493-498.
[6]Xie C,Wang DH. Ablation of transient receptor potential vanilloid 1 abolishes endothelin-induced increases in afferent renal nerve activity:mechanisms and functional significance[J]. Hypertension,2009,54(6):1298-1305.
[7]Foss JD,Wainford RD,Engeland WC,et al. A novel method of selective ablation of afferent renal nerves by periaxonal application of capsaicin[J]. Am J Physiol Regul Integr Comp Physiol,2015,308(2):R112-R122.
[8]Kopp UC,Olson LA,DiBona GF. Renorenal reflex responses to mechano- and chemoreceptor stimulation in the dog and rat[J]. Am J Physiol,1984,246(1 Pt 2):F67-F77.
[9]Frame AA,Carmichael CY,Kuwabara JT,et al. Role of the afferent renal nerves in sodium homeostasis and blood pressure regulation in rats[J]. Exp Physiol,2019,104(8):1306-1323.
[10] Stella A,Zanchetti A. Functional role of renal afferents[J]. Physiol Rev,1991,71(3):659-682.
[11]Katholi RE,Hageman GR,Whitlow PL,et al. Hemodynamic and afferent renal nerve responses to intrarenal adenosine in the dog[J]. Hypertension,1983,5(2 Pt 2):I149-I154.
[12]Smits JF,Brody MJ. Activation of afferent renal nerves by intrarenal bradykinin in conscious rats[J]. Am J Physiol,1984,247(6 Pt 2):R1003-R1008.
[13]Barry EF,Johns EJ. Intrarenal bradykinin elicits reno-renal reflex sympatho-excitation and renal nerve-dependent fluid retention[J]. Acta Physiol(Oxf),2015,213(3):731-739.
[14]Ye C,Qiu Y,Zhang F,et al. Chemical stimulation of renal tissue induces sympathetic activation and a pressor response via the paraventricular nucleus in rats[J]. Neurosci Bull,2020,36(2):143-152.
[15]Zheng F,Ye C,Wan GW,et al. Interleukin-1β in hypothalamic paraventricular nucleus mediates excitatory renal reflex[J]. Pflugers Arch,2020,472(11):1577-1586.
[16]Zheng H,Patel KP. Integration of renal sensory afferents at the level of the paraventricular nucleus dictating sympathetic outflow[J]. Auton Neurosci,2017,204:57-64.
[17]Haselton JR,Goering J,Patel KP. Parvocellular neurons of the paraventricular nucleus are involved in the reduction in renal nerve discharge during isotonic volume expansion[J]. J Auton Nerv Syst,1994,50(1):1-11.
[18]Zhou JJ,Ma HJ Shao JY,et al. Impaired hypothalamic regulation of sympathetic outflow in primary hypertension[J]. Neurosci Bull,2019,35(1):124-132.
[19]Chen HH,Cheng PW,Ho WY,et al. Renal denervation improves the baroreflex and GABA system in chronic kidney disease-induced hypertension[J]. Sci Rep,2016,6:38447.
[20]Milanez MIO,Veiga AC,Martins BS,et al. Renal sensory activity regulates the γ-aminobutyric acidergic inputs to the paraventricular nucleus of the hypothalamus in goldblatt hypertension[J]. Front Physiol,2020,11:601237.
[21]Patel KP,Xu B,Liu X,et al. Renal denervation improves exaggerated sympathoexcitation in rats with heart failure:a role for neuronal nitric oxide synthase in the paraventricular nucleus[J]. Hypertension,2016,68(1):175-184.
[22]Zheng H,Katsurada K,Liu X,et al. Specific afferent renal denervation prevents reduction in neuronal nitric oxide synthase within the paraventricular nucleus in rats with chronic heart failure[J]. Hypertension,2018,72(3):667-675.
[23]Frame AA,Carmichael CY,Wainford RD. Renal afferents[J]. Curr Hypertens Rep,2016,18(9):69.
[24]Ryan MJ. An update on immune system activation in the pathogenesis of hypertension[J]. Hypertension,2013,62(2):226-230.
[25]Veelken R,Vogel EM,Hilgers K,et al. Autonomic renal denervation ameliorates experimental glomerulonephritis[J]. J Am Soc Nephrol,2008,19(7):1371-1378.
[26]Trott DW,Harrison DG. The immune system in hypertension[J]. Adv Physiol Educ,2014,38(1):20-24.
[27]Banek CT,Knuepfer MM,Foss JD,et al. Resting afferent renal nerve discharge and renal inflammation:elucidating the role of afferent and efferent renal nerves in deoxycorticosterone acetate salt hypertension[J]. Hypertension,2016,68(6):1415-1423.
[28]Xiao L,Kirabo A,Wu J,et al. Renal denervation prevents immune cell activation and renal inflammation in angiotensinⅡ-induced hypertension[J]. Circ Res,2015,117(6):547-557.
[29]Ong J,Kinsman BJ,Sved AF,et al. Renal sensory nerves increase sympathetic nerve activity and blood pressure in 2-kidney 1-clip hypertensive mice[J]. J Neurophysiol,2019,122(1):358-367.
[30]Wyss JM,Aboukarsh N,Oparil S. Sensory denervation of the kidney attenuates renovascular hypertension in the rat[J]. Am J Physiol,1986,250(1 Pt 2):H82-H86.
[31]Oparil S,Sripairojthikoon W,Wyss JM. The renal afferent nerves in the pathogenesis of hypertension[J]. Can J Physiol Pharmacol,1987,65(8):1548-1558.
[32]Veiga AC,Milanez MIO,Ferreira GR,et al. Selective afferent renal denervation mitigates renal and splanchnic sympathetic nerve overactivity and renal function in chronic kidney disease-induced hypertension[J]. J Hypertens,2020,38(4):765-773.
[33]Foss JD,Fink GD,Osborn JW. Differential role of afferent and efferent renal nerves in the maintenance of early- and late-phase Dahl S hypertension[J]. Am J Physiol Regul Integr Comp Physiol,2016,310(3):R262-R267.
[34]Hering D,Marusic P,Walton AS,et al. Sustained sympathetic and blood pressure reduction 1 year after renal denervation in patients with resistant hypertension[J]. Hypertension,2014,64(1):118-124.
[35]Kandzari DE,B?hm M,Mahfoud F,et al. Effect of renal denervation on blood pressure in the presence of antihypertensive drugs:6-month efficacy and safety results from the SPYRAL HTN-ON MED proof-of-concept randomised trial[J]. Lancet,2018,391(10137):2346-2355.
[36]Weber MA,Kirtane AJ,Weir MR,et al. The REDUCE HTN:REINFORCE:randomized,sham-controlled trial of bipolar radiofrequency renal denervation for the treatment of hypertension[J]. JACC Cardiovasc Interv,2020,13(4):461-470.
相似文献/References:
[1]孙刚,黄冠华,综述.高血压合并心力衰竭的治疗策略[J].心血管病学进展,2016,(2):201.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.027]
SUN Gang,HUANG Guanhua.Treatment Strategy of Hypertension with Heart Failure[J].Advances in Cardiovascular Diseases,2016,(3):201.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.027]
[2]范贵娟,综述,徐瑞,等.盐敏感性高血压的研究进展[J].心血管病学进展,2016,(4):364.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.010]
FAN Guijuan,XU Rui.Research Progress of Salt Sensitive Hypertension[J].Advances in Cardiovascular Diseases,2016,(3):364.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.010]
[3]陈源源.钙通道阻滞剂在降压治疗中的应用[J].心血管病学进展,2015,(6):662.[doi:10.3969/j.issn.1004-3934.2015.06.002]
CHEN Yuanyuan.Application of Calcium Channel Blockers in Hypertension Treatment[J].Advances in Cardiovascular Diseases,2015,(3):662.[doi:10.3969/j.issn.1004-3934.2015.06.002]
[4]张瑞 毛露 孙硕 Dirk Hermann 陈艾东.内皮素-1干预成为高血压治疗新靶点的展望[J].心血管病学进展,2019,(7):969.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.000]
ZHANG Rui MAO LuSUN ShuoDIRK Hermann CHEN Aidong.The Prospect of Endothelin-1 Intervention as A New Target for the Treatment of Hypertension[J].Advances in Cardiovascular Diseases,2019,(3):969.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.000]
[5]张毅,柳志红.动态血压监测在高血压中的应用现状与问题[J].心血管病学进展,2019,(6):848.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.003]
ZHANG Yi,LIU Zhihong.Current status and nsolved Pproblems of Ambulatory Blood Pressure Monitoring for the Management of Hypertension[J].Advances in Cardiovascular Diseases,2019,(3):848.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.003]
[6]黄秋瑾 胡蓉.高血压合并糖尿病患者血压控制率和控制目标的探讨[J].心血管病学进展,2019,(7):973.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.002]
HUANG QiujinHU Rong.Discussion on Blood Pressure Control Rate and Control Target in Patients with Hypertension Complicated with Diabetes[J].Advances in Cardiovascular Diseases,2019,(3):973.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.002]
[7]张旭明 王曦.高血压对认知功能的影响[J].心血管病学进展,2019,(7):977.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.003]
ZHANG Xuming,WANG Xi.The Relationship Between Hypertension and Cognitive Function[J].Advances in Cardiovascular Diseases,2019,(3):977.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.003]
[8]凌梦军 陈明凌梦军.阻塞性睡眠呼吸暂停低通气综合征与高血压关系的研究进展[J].心血管病学进展,2019,(5):722.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.015]
[9]李波 郭毅 田进文 邓珏琳.高血压合并2型糖尿病的治疗进展[J].心血管病学进展,2019,(9):1196.[doi:10.16806/j.cnki.issn.1004-3934.2019.09.002]
LI Bo,GUO Yi,TIAN Jinwen,et al.Therapy in Hypertensive Patients with Type 2 Diabetes Mellitus[J].Advances in Cardiovascular Diseases,2019,(3):1196.[doi:10.16806/j.cnki.issn.1004-3934.2019.09.002]
[10]王继航 赵施皓 李开亮 田进文 李玉龙 付士辉 沈明志 邓珏琳.远程医疗在高血压病管理中的研究进展[J].心血管病学进展,2019,(9):1199.[doi:10.16806/j.cnki.issn.1004-3934.2019.09.003]
WANG Jihang,ZHAO Shihao,LI Kailiang,et al.Telemedicine in Hypertension Management[J].Advances in Cardiovascular Diseases,2019,(3):1199.[doi:10.16806/j.cnki.issn.1004-3934.2019.09.003]